R Yu, L Chen, R Lan, R Shen, P Li - International journal of antimicrobial …, 2020 - Elsevier
… In the current spread of novel coronavirus (SARS-CoV-2), antiviral drug discovery is of … by moleculardocking with the structural protein and non-structural protein sites of new coronavirus…
… The inhibition of the SARS-CoV-2 main protease is necessary for the blockage of the viral … a blind moleculardocking approach to identify the possible inhibitors of the SARS-CoV-2 main …
KA Peele, CP Durthi, T Srihansa, S Krupanidhi… - Informatics in medicine …, 2020 - Elsevier
The aim of this study was to develop an appropriate anti-viral drug against the SARS-CoV-2 virus. An immediately qualifying strategy would be to use existing powerful drugs from …
… with the possible binding sites of SARS-CoV-2, we performed moleculardocking studies. … moleculardocking studies of EGCG and TF3 with possible active binding sites of SARS-CoV…
… activity against SARS-CoV-2. … moleculardocking in order to assess the binding affinity of different viral proteins to different drugs with potential antiviral activities against SARS-CoV…
F Rahman, S Tabrez, R Ali, AS Alqahtani… - Journal of traditional and …, 2021 - Elsevier
… Moleculardocking is one of the most popular methods in the field of computer-aided … Moleculardocking is used to identify Rutin as a potentially active phytochemical against SARSCoV-…
In this article, we report results of a moleculardocking analysis of commonly occurring natural product compounds against COVID-19 6LU7 and 6Y2E proteases. Our results show that …
… SARS-CoV-2. Lipinski’s rule was taken as the foundation for initial screening. Shortlisted … were subjected to moleculardocking study with M pro receptor present in SARS-CoV-2. The …
… In the present research, the moleculardocking analysis affirmed that all the ligands from the natural compounds interacted with the active site of the target protease. The nature and …